Annora Pharma Private Limited Famotidine Export Data — India (DGFT 2022–2026)

Name: Annora Pharma Private Limited Famotidine Export Records India — #2 Exporter, 435 Shipments, $8.1M FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-05-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Famotidine

India Pharmaceutical Trade Intelligence

$55.8M152 Suppliers66 CountriesHS 30049039

ExportsIndia → UNITED STATES84.0%India → JAPAN4.4%

ImportsISRAEL → India$2.8M UNITED STATES → India$121.0K

#1 Supplier: VKT PHARMA #1 Buyer: MYLAN INSTITUTIONAL

Annora Pharma Private Limited — Famotidine Exporter #2 | $8.1M Trade Value | TransData Nexus | TransData Nexus

Annora Pharma Private Limited — Famotidine Exporter Profile

Indian Pharmaceutical Exporter · #2 for Famotidine · $8.1M export value · DGFT Verified

Annora Pharma Private Limited is the #2 Indian exporter of Famotidine with $8.1M in export value and 435 verified shipments. Annora Pharma Private Limited holds a 14.5% market share in Famotidine exports across 3 countries. The company exports 13 pharmaceutical products worth $56.8M across 9 therapeutic categories.

Annora Pharma Private Limited — Famotidine Export Profile: Buyers & Destinations

Annora Pharma Private Limited Famotidine export treemap — buyers and destination countries | TransData Nexus

Where Does Annora Pharma Private Limited Export Famotidine?

Country	Value	Shipments	Share
UNITED STATES	$7.1M	420	96.4%
EL SALVADOR	$149.2K	8	2.0%
UNITED STATES OF AMERICA	$83.4K	4	1.1%
CHILE	$31.2K	3	0.4%

Who Are the Top Buyers of Famotidine from Annora Pharma Private Limited?

Buyer	Country	Value	Orders
TO THE ORDER OF	UNITED STATES	$3.1M	175
TO THE ORDER OF....	UNITED STATES	$2.7M	149
CAMBER PHARMACEUTICALS INC	UNITED STATES	$765.9K	66
TO THE ORDER	UNITED STATES	$297.0K	12
M/S.	UNITED STATES	$186.2K	9
M STO THE ORDER OFCAMBER PHARMACEUTICALS INC	UNITED STATES	$77.3K	2
TO THE ORDER OF.	UNITED STATES	$41.8K	6
M/S	UNITED STATES	$35.2K	2
SEVEN PHARMA CHILE SPA	CHILE	$31.2K	3
TO THE ORDER OF . , . ,,, , , , , ,	EL SALVADOR	$30.8K	1

Annora Pharma Private Limited supplies Famotidine to 13 buyers globally. The largest buyer is TO THE ORDER OF (UNITED STATES), followed by TO THE ORDER OF.... (UNITED STATES) and CAMBER PHARMACEUTICALS INC (UNITED STATES). These buyers represent pharmaceutical distributors, hospital groups, and government procurement agencies in their respective markets.

What Famotidine Formulations Does Annora Pharma Private Limited Export?

Product Description / Formulation	Value	Shipments
FAMOTIDINE TABS	$2.4M	145
FAMOTIDINE TABSNOS	$756.5K	99
FAMOTIDINE 40MG TABS	$721.3K	26
FAMOTIDINE 20MG TABS	$690.9K	35
FAMOTIDINE 20MG TABS (4272x1000's PACK)	$455.1K	12
FAMOTIDINE 20MG TABSNOS	$214.8K	21
FAMOTIDINE 40MG/5ML SOLUTION	$200.0K	4
FAMOTIDINE 40MG TABSNOS	$154.8K	12
FAMOTIDINE SOLUTION	$150.0K	3
FAMOTIDINE CAPS	$149.2K	8

Annora Pharma Private Limited exports 55 distinct Famotidine formulations including tablets, capsules, syrups, and combination drugs. The top formulation is FAMOTIDINE TABS with 145 shipments worth $2.4M.

How Does Annora Pharma Private Limited Compare to Nearest Famotidine Exporters?

Exporters ranked immediately above and below #2 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
1	VKT PHARMA PRIVATE LIMITED	$8.7M	173	2	$50.0K
2	ANNORA PHARMA PRIVATE LIMITED ★	$8.1M	435	3	$18.6K
3	MYLAN LABORATORIES LIMITED	$7.5M	212	2	$35.6K
4	ALEMBIC PHARMACEUTICALS LIMITED	$4.3M	124	2	$34.6K

Annora Pharma Private Limited ranks #2 among 152 Indian Famotidine exporters. Average shipment value of $18.6K compared to the market average of $265.7K. The closest competitors by value are VKT PHARMA PRIVATE LIMITED and MYLAN LABORATORIES LIMITED.

Which Indian Ports Ship Famotidine Exports?

Port	Shipments	% Share
DELHI AIR CARGO ACC (INDEL4)	264	9.6%
HYDERABAD ICD	251	9.1%
SAHAR AIR	239	8.7%
DELHI AIR	188	6.8%
NHAVA SHEVA SEA (INNSA1)	163	5.9%
SAHAR AIR CARGO ACC (INBOM4)	155	5.6%
HYDERABAD ICD (INSNF6)	153	5.6%
HYDERABAD AIR	86	3.1%

Geopolitical & Trade Policy Impact on Annora Pharma Private Limited's Famotidine Exports

The current geopolitical landscape presents both challenges and opportunities for Indian pharmaceutical exporters like Annora Pharma. The Israel-Iran conflict has led to disruptions in the Red Sea shipping routes, causing maritime carriers to suspend bookings and reroute vessels around the Cape of Good Hope. These changes have resulted in increased lead times and freight costs, disproportionately affecting time-sensitive pharmaceutical shipments. The Pharmaceutical Export Promotion Council of India (Pharmexcil) estimates potential losses ranging from ₹2,500 crore to ₹5,000 crore due to these disruptions. (fortuneindia.com)

Conversely, the U.S.-China trade tensions have created openings for Indian pharmaceutical companies. With the U.S. imposing tariffs on Chinese goods, Indian exporters have an opportunity to capture a larger share of the American market. However, this advantage is tempered by the U.S. administration's pressure on pharmaceutical companies to lower drug prices and the potential for increased tariffs on imported pharmaceuticals, which could impact profit margins. (lemonde.fr)

In the European Union, the implementation of the Falsified Medicines Directive (FMD) has introduced stringent regulations aimed at preventing counterfeit drugs from entering the supply chain. Compliance with these regulations requires significant investment in serialization and traceability systems. For companies like Annora Pharma, adhering to these standards is crucial to maintain access to the lucrative EU market.

Annora Pharma Private Limited — Regulatory Compliance & Quality Standards

Regulatory compliance remains a critical factor for Indian pharmaceutical exporters. The U.S. Food and Drug Administration (FDA) has intensified inspections of Indian manufacturing facilities, with over 200 inspections conducted in 2023 and plans to increase this number in 2024. Non-compliance can lead to warning letters, import alerts, and bans, severely impacting export capabilities. (fact.net.in)

Annora Pharma's involvement in a patent infringement lawsuit with BioCryst Pharmaceuticals highlights the importance of navigating intellectual property rights carefully. Ensuring that generic products do not infringe on existing patents is essential to avoid legal disputes that can delay market entry and result in financial liabilities.

Maintaining high-quality standards and adhering to Good Manufacturing Practices (GMP) are imperative for sustaining credibility and competitiveness in international markets. Investing in robust quality control systems and staying abreast of evolving regulatory requirements will be key for Annora Pharma's continued success.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Famotidine shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: Annora Pharma Private Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.
4.Verified Records: This page is backed by 435 individual customs records matching Annora Pharma Private Limited exporting Famotidine, covering 55 formulations to 4 countries via 13 buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 66+ countries, 302+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Famotidine

Famotidine

Annora Pharma Private Limited — Famotidine Exporter Profile

Annora Pharma Private Limited — Famotidine Export Profile: Buyers & Destinations

Where Does Annora Pharma Private Limited Export Famotidine?

Who Are the Top Buyers of Famotidine from Annora Pharma Private Limited?

What Is India's Total Famotidine Export Value and How Much Does Annora Pharma Private Limited Contribute?

What Is the Average Shipment Value for Annora Pharma Private Limited's Famotidine Exports?

How Does Annora Pharma Private Limited Compare to Other Indian Famotidine Exporters?

What Famotidine Formulations Does Annora Pharma Private Limited Export?

Regulatory Requirements: Exporting Famotidine to Key Markets

United States — FDA

How Does Annora Pharma Private Limited Compare to Nearest Famotidine Exporters?

Which Indian Ports Ship Famotidine Exports?

What Other Gastrointestinal Products Does Annora Pharma Private Limited Export?

Geopolitical & Trade Policy Impact on Annora Pharma Private Limited's Famotidine Exports

Annora Pharma Private Limited — Regulatory Compliance & Quality Standards

About Annora Pharma Private Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Famotidine Export Data from Annora Pharma Private Limited

Famotidine Stats

Company Overview

Top Products by Annora Pharma Private Limited

Related Analysis

Need Detailed Export Data?

Data Source